Stockscreener 앱 받기
4.83
3.98%
-0.20
시간 외 거래:
4.84
0.010
+0.21%
Alvotech 주식(ALVO)의 최신 뉴스
Alvotech (NASDAQ: ALVO) Schedules Nov 13 Earnings Call on First Nine Months 2025 - Stock Titan
Alvotech Shares Fall After Deutsche Bank Downgrade - MarketScreener
Alvotech (NASDAQ:ALVO) Reaches New 52-Week LowHere's What Happened - MarketBeat
Alvotech SA Securities Lawsuit Investigation - Claim Depot
Alvotech stock hits 52-week low at 5.82 USD By Investing.com - Investing.com Australia
Alvotech price target lowered to $10 from $28 at Northland - TipRanks
Deutsche Bank Downgrades Alvotech to Hold From Buy, Cuts Price Target to $8 From $14 - MarketScreener
Alvotech plant issues foil another FDA review, this time for Teva-partnered Simponi biosimilar - Fierce Pharma
Deutsche Bank downgrades Alvotech stock to Hold on manufacturing issues By Investing.com - Investing.com UK
Will Alvotech stock reach all time highs in 2025July 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Deutsche Bank Downgrades Alvotech (ALVO), Lowers Price Target to $8.00 | ALVO Stock News - GuruFocus
This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - inkl
Alvotech (NASDAQ: ALVO) sets 10:45 am EDT fireside chat on Sept 10 with webcast - Stock Titan
Deutsche Bank downgrades Alvotech stock to Hold on manufacturing issues - Investing.com
How Alvotech (Z45) stock trades under stagflation2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Risk adjusted return profile for Alvotech analyzed2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
FDA Rejects Alvotech’s Biosimilar AVT05 for Simponi Citing Manufacturing Deficiencies - geneonline.com
Is Alvotech stock a smart buy before Fed meetingJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Will Alvotech Equity Warrant stock deliver shareholder valueWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Alvotech faces FDA setback for its Simponi biosimilar AVT05 - Pharmaceutical Technology
Trend analysis for Alvotech this weekMarket Risk Summary & Community Consensus Picks - newser.com
A Look at Alvotech (NasdaqGM:ALVO) Valuation Following FDA Setback and 2025 Outlook Revision - simplywall.st
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation Following Recent Share Price Decline - Yahoo! Finance Canada
ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors ... - Bluefield Daily Telegraph
ALVO Investor ALERT: Block & Leviton Investigating Alvotech - GlobeNewswire
Gold Edges Higher; ISM Manufacturing PMI Falls In October - Benzinga
Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO) - Seeking Alpha
Alvotech Shares Plunge 33% After FDA Flags Issues - Benzinga
Alvotech fell heavily on the Stockholm Stock Exchange, and the OMXS30 index fell 0.4 percent. - MarketScreener
Alvotech drops after US FDA declines to approve arthritis drug - TradingView
Alvotech stock hits 52-week low at 5.82 USD - Investing.com
What technical patterns form on Alvotech (Z45) stock chartsJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
What analysts say about Alvotech Z45 stockSwing Trading Watchlist & Low Investment Wealth Tips - earlytimes.in
Alvotech Shares Slide After FDA Requests Further Action on Simponi Biosimilar - MSN
Applying Wyckoff theory to Alvotech Equity Warrant stockMarket Activity Report & High Accuracy Investment Signals - newser.com
Will Alvotech (Z45) stock rise with strong economy2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
Is Alvotech stock positioned for digital transformationJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
How Alvotech stock performs in high volatility markets2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Alvotech stock falls after FDA issues complete response letter By Investing.com - Investing.com Australia
Alvotech stock falls after FDA issues complete response letter - Investing.com
Alvotech Hit By FDA Setback On Key Arthritis Drug - Finimize
Alvotech Equity Warrant stock daily chart insights2025 Fundamental Recap & Technical Buy Zone Confirmations - newser.com
Alvotech falls heavily on the Stockholm Stock Exchange, OMXS30 index rises 0.2 percent - MarketScreener
Alvotech Shares Plunge As FDA Declines To Approve AVT05, A Biosimilar To Simponi - Nasdaq
Alvotech Faces FDA Setback for AVT05 Biosimilar Application - TipRanks
What candlestick patterns are forming on AlvotechTrade Risk Summary & Stepwise Entry and Exit Trade Signals - newser.com
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook - MSN
What the charts say about Alvotech Equity Warrant today2025 Retail Activity & Real-Time Volume Triggers - newser.com
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook (ALVO:NASDAQ) - Seeking Alpha
Applying chart zones and confluence areas to AlvotechWatch List & Stepwise Trade Signal Guides - newser.com
Bittersweet Simponi Verdict For Alvotech As US FDA Knocks Back Golimumab Filing - Citeline News & Insights
Why Alvotech Shares Are Facing Turbulence - TipRanks
Will Alvotech stock benefit from AI adoptionQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Has Alvotech formed a bullish divergence2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Alvotech (ALVO) Stock: Slips Amid FDA Setback on Simponi Biosimilar AVT05 - parameter.io
Using RSI to spot recovery in Alvotech Equity Warrant2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Can Alvotech (Z45) stock survive global slowdownWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com
Detecting price anomalies in Alvotech Equity Warrant with AIJuly 2025 Review & Free Technical Pattern Based Buy Signals - newser.com
3.60%
0.45%
자본화:
|
볼륨(24시간):